Marlene Montesino

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Fernand Labrie, David F. Archer, William Koltun et al. · Menopause The Journal of The North American Menopause Society · 2016 · 244 citations

Medicine, Gynecology, Pharmacotherapy +17

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Fernand Labrie, David F. Archer, William Koltun et al. · Menopause The Journal of The North American Menopause Society · 2018 · 115 citations

Medicine, Gynecology, Pharmacotherapy +17

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy

Fernand Labrie, Leonard R. Derogatis, David F. Archer et al. · The Journal of Sexual Medicine · 2015 · 89 citations

Medicine, Endocrinology, Gynecology +15

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5 mg intravaginal prasterone for 12 weeks

Céline Martel, Fernand Labrie, David F. Archer et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2016 · 73 citations

Medicine, Endocrinology, Pharmacotherapy +15

Combined data of intravaginal prasterone against vulvovaginal atrophy of menopause

Fernand Labrie, David F. Archer, Céline Martel et al. · Menopause The Journal of The North American Menopause Society · 2017 · 45 citations

Medicine, Endocrinology, Gynecology +17